Who
Stephan Toutain
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, PDS Biotechnology; Chief Commercial Officer, Interleukin Genetics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 20 Oct 2016
- Last trade
- 12 Jan 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jan 2026filed 3 Mar 2026 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 12 Jan 2026filed 3 Mar 2026 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 12 Jun 2025filed 25 Jul 2025 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 1 May 2024filed 2 May 2024 | PDSB PDS Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 19 Apr 2017filed 12 May 2017 | Interleukin Geneticsoption or derivative | SEC FORM 4 Code A | —182,547 at $0.00 | filing |
| 25 Jan 2017filed 26 Jan 2017 | Interleukin Geneticsoption or derivative | SEC FORM 4 Code A | —365,093 at $0.00 | filing |
| 20 Oct 2016filed 21 Oct 2016 | Interleukin Geneticsoption or derivative | SEC FORM 4 Code A | —3,738,933 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.